07.01.04
Novogen, Sydney, Australia, has been granted patent coverage over its OTC products being sold in Canada. The patent covers the isoflavone composition of the products Promensil™, Rimostil™ and Trinovin™. Additionally the patent covers the use of isoflavone health supplements for the treatment of menopause symptoms.